Early research (Phase 1)Study completedNCT01809210
What this trial is testing
Assess Safety & Efficacy of Selumetinib When Given in Combination With Standard First Line Treatment for Advanced Non-small Cell Lung Cancer
Who this might be right for
Locally Advanced or Metastatic NSCL Cancer Stage IIIB IV
AstraZeneca 55